Charite BIH Innovation
Charité/BIH and Enterprise Singapore (ESG) have established an innovation support program that promotes cooperation between excellent clinicians from Charité/BIH and start-ups from Singapore. Following the successful application of start-ups from Singapore, we are now looking for project partners at Charité/BIH.
On 28 February 2024, the team from Charité BIH Innovation (CBI) - the joint technology transfer of Charité - Universitätsmedizin Berlin and the Berlin Institute of Health (BIH) - was delighted to receive a visit from Prof. Heyo. K. Kroemer, Chairman of the Executive Board of Charité, Prof. Dr Joachim Spranger, Dean of Charité, Prof. Dr Christopher…
Charité/BIH spin-off TimeTeller GmbH has been named winner of the Health Innovation Award 2023.
Twice a year, the start-up competition Gründungswettbewerb – Digitale Innovationen by the Federal Ministry for Economic Affairs and Climate Protection's (BMWK) honors the best ideas of innovative start-ups that are based on digital technologies. The award supports start-ups in the early stages and emphasizes their key role as drivers of innovation…
With its innovative ultrasound procedure, the spin-off PoroUS GmbH, in which Charité holds a stake via its technology service provider Ascenion GmbH, enables cost-effective, X-ray-free and precise early detection of osteoporosis. The Potsdam-based start-up, led by Dr Julia Eschenbrenner (CEO), Jonas Massmann (CTO) and Charité employee Prof Dr Kay…
On November 10, 2023 a significant milestone was reached when Charité - Universitätsmedizin Berlin, Berlin Institute of Health at Charité (BIH) and Enterprise Singapore signed a Memorandum of Understanding (MoU). This forms the basis for the upcoming launch of the Co-Innovation Program. This innovative program facilitates the professional…
Again, this year the SPARK-BIH funding and mentoring program motivated many scientists and clinicians from Charité – Universitätsmedizin Berlin and the Berlin Institute of Health at Charité (BIH) to submit their translational project proposals in the fields of pharma, diagnostics and medtech. The applicants presented their proposals to an expert…
Charité - Universitätsmedizin Berlin and the Israel Innovation Authority (IIA) launched a joint program in 2020 aimed at promoting and validating innovations in the field of digital medicine and medical technology. This collaborative project was relaunched in 2022 under the title "International Health-Tech R&D and Pilot Program". First and…
Apply by November 3, 2023 to the BIH Digital Health Accelerator Program, which provides funding to help you translate your digital health venture.
On May 31, 2023, the sixth annual Demo Day of the BIH Digital Health Accelerator Program took place, bringing together a diverse group of innovative minds in the heart of Berlin. The event, hosted by the Berlin Institute of Health at Charité (BIH), showcased seven exceptional teams of Charité/BIH clinicians and researchers presenting their digital…
The SPARK-BIH program of the Berlin Institute of Health at Charité supports translational projects from Charité and BIH with funding as well as coaching and mentoring by an international network of experts. Why not let the SPARK-BIH program support you in enhancing the translatability of your innovative technology for the benefit of patients.
A fruitful and dynamic technology transfer is indispensable to make results from science and research usable for patients. Charité BIH Innovation offers a wide range of service units and funding instruments for the implementation of innovative ideas. This innovation ecosystem is now complemented by the new Idea Office – the contact point for…
After a three-day pitch event in September, an expert jury selected fourteen outstanding translational projects for funding by the BIH / the NeuroCure cluster of excellence. The teams at SPARK-BIH and NeuroCure welcomed the new SPARKees during an onboarding event and are excited to support the translation of their medical innovation from bench to…
After two years of intensive renovation work, the new location of Charité BIH Innovation (CBI) - the joint technology transfer of Charité and BIH - has opened on October 12. Covering a total of 2,500 m2 spread over four floors, the modern, expanded new-work space (Am Zirkus/ Bertolt-Brecht-Platz 3, 10117 Berlin) unites a wide variety of development…
In May 2022, after more than 15 years of intensive research activity at Charité Universitätsmedizin Berlin, Dr. Wallach joined the team of the in-house technology transfer office Charité BIH Innovation (CBI) as technology manager. Now, due to his great ambition and potential for detecting, managing and protecting promising scientific discoveries,…
The newly formed research collaboration between Pantherna Therapeutics and clinical researchers at Charité – Universitätsmedizin Berlin aims at investigating the potential of therapeutic mRNA in autoimmune diseases. Charité BIH Innovation offers consultation and support during the translational process.
The BIH DHA spin-off AIgnostics successfully closes a €14 million Series A round to enter additional markets.
MyoPax, a new spin-off of the Max Delbrück Center and Charité, is receiving a €1.3 million loan to jump-start its business development. The start-up uses its innovative stem cell technology to create regenerative therapies for previously incurable muscle diseases. The BIH has provided support and guidance to the spin-off through SPARK-BIH, a…
Felix Krenzien and his team attracted the grant from the Else Kröner-Fresenius-Stiftung (EKFS) to translate their new approach for quantifying extracellular NAD+ into medical practice.
During an epileptic seizure, groups of neurons suddenly fire all at once, leading to involuntary movements and sensations. Possibilities for helping those who suffer from epilepsy are limited. EpiBlok Therapeutics GmbH was recently founded by scientists from Charité and the Medical University of Innsbruck. The company is developing a type of gene…
Acute kidney injury (AKI) is commonly seen in hospitals. It entails the rapid deterioration of kidney function, a high disease burden, and leads in some cases to death. The team at Nephrolytix GmbH, a new spin-off of Charité – Universitätsmedizin Berlin, has developed a process with the potential to reduce the time it takes to detect AKI –…
As a manufacturer of AI-based software for predicting complications after serious heart surgery, x-cardiac GmbH has successfully completed the certification of its quality management system according to ISO 13485. (German Press Release)
The International Health-Tech Pilot Program promotes forward-looking healthcare solutions from Israel. Now, the first collaboration agreements between Israeli start-up companies, Charité-Universitätsmedizin Berlin, the Berlin Institute of Health at Charité (BIH) and the Israel Innovation Authority have been successfully concluded. The collaboration…
SPARK-BIH funded ATMP project has published first results in the Journal for ImmunoTherapy of Cancer.
x-cardiac GmbH has been certified as a medical device manufacturer in the EU while at the same time receiving market authorization for its first medical device x-c-bleeding. The AI-based software can quickly predict the risk of postoperative bleeding in patients. Specialists at the German Heart Center Berlin (DHZB) developed the software and…
The Charité was named one of the most innovative companies in Germany by the magazine Capital. An article about BIH as a driver of digital innovation and presentation of the Digital Health Accelerator.
On May 19, 2021, the BIH Digital Health Accelerator (DHA) Demo Day took place for the fourth time. The DHA program is carried out by Charité BIH Innovation, the joint technology transfer office of Charité - Universitätsmedizin Berlin and the Berlin Institute of Health (BIH), for the development of digital health solutions and their translation into…
Since the start of the Covid-19 pandemic, the global healthcare sector is in the spotlight now more than ever before. Despite the challenging nature of these times, we have witnessed amazing advances in the healthcare and life science innovation space.
